Transforming Your Body into a GLP-1 Factory

Two biotech startups, RenBio and Fractyl Health, are developing gene therapies to turn cells into factories producing GLP-1, a hormone that aids weight loss and blood sugar regulation, potentially offering a long-lasting alternative to current medications like Ozempic. These approaches have shown promising results in animal studies, with human trials anticipated in the near future, aiming to provide safer, more effective obesity treatments.